Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Fibronectin (FN) oral agent for preventing and curing gastric and intestinal ulcers

A technology of fibronectin and oral preparations, which is applied in the direction of peptide/protein components, anti-drugs, medical preparations containing active ingredients, etc., can solve problems that have not been seen, achieve significant effects, improve immunity, and improve mucosal cell metabolism effect of ability

Inactive Publication Date: 2014-05-28
王斌
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] But so far there is no oral agent that uses fibronectin (FN) as an active ingredient to prevent and treat gastrointestinal ulcers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0025] Example 1: Regular crowd

[0026] Taking 1000ml of the FN oral liquid of the present invention as an example, each component is weighed according to the following dosages: fibronectin: 0.6g, small molecule peptide 0.3g, lysozyme 10g, isomaltose 200g.

[0027] The preparation method is: add pure water to the set volume of 1000ml, filter and sterilize with a 0.22μm filter membrane, then add isomaltose (after cooling to 40-50℃), lysozyme, and stir Uniform and aseptic subpackage to obtain the fibronectin oral liquid of the present invention.

[0028] According to demand, fibronectin oral water can be freeze-dried into freeze-dried powder dosage form by freeze-drying machine.

example 2

[0029] Example 2: Types of diabetes

[0030] Taking 1000ml of the FN oral liquid of the present invention as an example, each component is weighed according to the following dosages: fibronectin: 0.7g, small molecule peptide 0.4g, lysozyme 15g, xylitol 200g.

[0031] The preparation method is the same as Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a fibronectin (FN) oral agent for preventing and curing gastric and intestinal ulcers. The FN oral agent is characterized by comprising the following components in percentage by weight: 0.05-0.20% of FN, 0.01-0.15% of active small molecule peptide, 1-5% of lysyme, 10-20% of sweetening agent and the balance of water. The FN oral agent disclosed by the invention takes the bioactive ingredient, namely FN, as a core functional component assisted by the active small molecule peptide, lysyme, xylitol and the like, so that the FN oral agent can effectively promote proliferation of mucous epithelium and cells, can participate in cell metabolism and activate the cells, and not only can effectively cure peptic ulcers including gastric ulcer, duodenal ulcer and the like, but also can achieve effects of resisting aging, maintaining beauty, improving immunity and the like.

Description

[0001] technical field [0002] The invention relates to an oral agent for preventing and treating gastrointestinal ulcers, in particular to a fibronectin oral agent for preventing and treating gastrointestinal ulcers. Background technique [0003] With the acceleration of the pace of social life in our country and changes in the environment and lifestyle, the incidence of peptic ulcer caused by smoking, drinking, emotional stress and drug stimulation has increased year by year, becoming a common and frequently-occurring disease with a high recurrence rate , the annual recurrence rate is as high as 70%, and the treatment is very difficult. At present, the commonly used clinical treatment method is the combined application of western medicine and traditional Chinese medicine. The specific combination depends on the habits of doctors. There is no big difference in the results, but it is accompanied by certain side effects. With the improvement of people's living standards, p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/47A61P1/04A61P39/06A61K38/39
Inventor 王斌桑喜成于凤霞贾秀秀杨敏祺许义辉张世阳
Owner 王斌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com